Keyword: Donald Trump

A top pharma CEO says President Trump is right to say other countries benefit from higher U.S. drug prices, but he’s not sold on proposals for a fix.

There's been no shortage of drug pricing talk in recent weeks, and now Merck's and Pfizer's CEOs have had a chance to voice their thoughts.

While the administration wants to attack "global freeloading" and reduce U.S. prices, some companies are set to feel the pain more than others.

It's no secret that drug prices are higher in the U.S. than in other countries, and now the Trump administration appears poised to act.

It's common for drugmakers to offer behind-the-scenes rebates to win coverage for their drugs. But Amgen's big retail price cut is a rare move.

Pharma has come under political pressure in Washington, D.C., and lobby spending figures indicate the industry is taking the threat seriously.

Big biopharma CEOs gave most or all their campaign contributions to Republicans this season, but one went full blue with his $120,000.

Pharma might have thought it could fend off the Trump administration's bid to get drug prices into consumer advertising, but it was wrong.

From pharma exec to attorney general? HHS Secretary Alex Azar is on a list of candidates to replace Jeff Sessions if he resigns, the WSJ reports.

The FDA is updating its citizen petition review policy to consider whether branded companies are filing the requests to delay generics competition.